Explore more publications!
Health News of Alabama
Submit Press Release

Health News of Alabama: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 22, 2025

UFC® and Smith+Nephew announce multi-year extension of partnership
October 22, 2025

UFC® and Smith+Nephew announce multi-year extension of partnership

Indeterminate GlobeNewswire
Strata’s LIFT25 Summit Showcases AI, Data, and Platform Innovation to Strengthen Healthcare Financial Performance
October 22, 2025

Strata’s LIFT25 Summit Showcases AI, Data, and Platform Innovation to Strengthen Healthcare Financial Performance

Indeterminate GlobeNewswire
Fangzhou Unveils “AI + Weight Management” Innovation at China’s Inaugural National-Level Weight Management Symposium in Beijing
October 22, 2025

Fangzhou Unveils “AI + Weight Management” Innovation at China’s Inaugural National-Level Weight Management Symposium in Beijing

Indeterminate GlobeNewswire
Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray
October 22, 2025

Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray

Indeterminate GlobeNewswire
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
October 22, 2025

Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting

Indeterminate GlobeNewswire
Webinar to Help New Jersey Parents and Employers Understand the Rising Risks of High-Potency Marijuana
October 22, 2025

Webinar to Help New Jersey Parents and Employers Understand the Rising Risks of High-Potency Marijuana

Indeterminate GlobeNewswire
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
October 22, 2025

BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio

Indeterminate GlobeNewswire
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
October 22, 2025

Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause

Indeterminate GlobeNewswire
Akari Therapeutics Announces Launch of CEO Corner Platform
October 22, 2025

Akari Therapeutics Announces Launch of CEO Corner Platform

Indeterminate GlobeNewswire
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment
October 22, 2025

HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment

Indeterminate GlobeNewswire
Aeroflow Health Wins 2025 HME Provider of the Year Award
October 22, 2025

Aeroflow Health Wins 2025 HME Provider of the Year Award

Indeterminate GlobeNewswire
Wake-Up Call: Aeroflow Sleep Survey Reveals a Growing Gap in Sleep Health Education and the Rise of DIY Sleep Trends
October 22, 2025

Wake-Up Call: Aeroflow Sleep Survey Reveals a Growing Gap in Sleep Health Education and the Rise of DIY Sleep Trends

Indeterminate GlobeNewswire
ADARx Pharmaceuticals Announces First Patient Dosed in Phase 3 STOP-HAE Clinical Trial and Orphan Drug Designation for ADX-324, a Long-Acting siRNA in Development for the Prophylactic Treatment of Hereditary Angioedema (HAE)
October 22, 2025

ADARx Pharmaceuticals Announces First Patient Dosed in Phase 3 STOP-HAE Clinical Trial and Orphan Drug Designation for ADX-324, a Long-Acting siRNA in Development for the Prophylactic Treatment of Hereditary Angioedema (HAE)

Indeterminate GlobeNewswire
Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe
October 22, 2025

Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe

Indeterminate GlobeNewswire
SELLAS Life Sciences to Participate in the J.P. Morgan U.S. Opportunities Forum
October 22, 2025

SELLAS Life Sciences to Participate in the J.P. Morgan U.S. Opportunities Forum

Indeterminate GlobeNewswire
Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET
October 22, 2025

Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET

Indeterminate GlobeNewswire
24/7 Market News- Kraig Labs Scalable Spider Silk May Unlock the Future of Lightweight Body Armor and Ballistic Protection
October 22, 2025

24/7 Market News- Kraig Labs Scalable Spider Silk May Unlock the Future of Lightweight Body Armor and Ballistic Protection

Indeterminate GlobeNewswire
Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025
October 22, 2025

Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025

Indeterminate GlobeNewswire
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System
October 22, 2025

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System

Indeterminate GlobeNewswire
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
October 22, 2025

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions